Multidisciplinary Tumour Board
Congress Hall
Congress Hall
Date
Wed, 30.03.2022
Time
14:30 - 16:00
Chairs
- Roy S. Herbst, New heaven, US
Location
Congress Hall
What to do after immunotherapy failure and when to avoid immunotherapy in early disease NSCLC
Multidisciplinary Tumour Board
Case presentation (ID 5)
Session Name
Room
Congress Hall
Date
Wed, 30.03.2022
Time
14:30 - 16:00
Duration
10 Minutes
Lecture Time
14:30 - 14:40
What to do after immunotherapy failure and when to avoid immunotherapy in early disease NSCLC
Multidisciplinary Tumour Board
What is the role of chemotherapy and antiangiogenics? (ID 6)
Speakers
- Roy S. Herbst, New heaven, US
Session Name
Room
Congress Hall
Date
Wed, 30.03.2022
Time
14:30 - 16:00
Duration
15 Minutes
Lecture Time
14:40 - 14:55
What to do after immunotherapy failure and when to avoid immunotherapy in early disease NSCLC
Multidisciplinary Tumour Board
IO rechallenge (ID 7)
Speakers
- Berber Piet, Nijmegen, NL
Session Name
Room
Congress Hall
Date
Wed, 30.03.2022
Time
14:30 - 16:00
Duration
15 Minutes
Lecture Time
14:55 - 15:10
What to do after immunotherapy failure and when to avoid immunotherapy in early disease NSCLC
Multidisciplinary Tumour Board
What to do after failure of immunotherapy in early disease? (ID 8)
Session Name
Room
Congress Hall
Date
Wed, 30.03.2022
Time
14:30 - 16:00
Duration
15 Minutes
Lecture Time
15:10 - 15:25
What to do after immunotherapy failure and when to avoid immunotherapy in early disease NSCLC
Multidisciplinary Tumour Board
Novel approaches (ID 9)
Speakers
- Jon Zugazagoitia, Madrid, ES
Session Name
Room
Congress Hall
Date
Wed, 30.03.2022
Time
14:30 - 16:00
Duration
15 Minutes
Lecture Time
15:25 - 15:40
What to do after immunotherapy failure and when to avoid immunotherapy in early disease NSCLC
Multidisciplinary Tumour Board
Discussion (ID 10)
Session Name
Room
Congress Hall
Date
Wed, 30.03.2022
Time
14:30 - 16:00
Duration
20 Minutes
Lecture Time
15:40 - 16:00